Treatment With Long Acting GnRH Antagonist Degarelix in Women With Endometriosis Recurrence
Phase of Trial: Phase III
Latest Information Update: 29 Apr 2016
Price : $35 *
At a glance
- Drugs Degarelix (Primary) ; Goserelin
- Indications Endometriosis
- Focus Therapeutic Use
- 25 Apr 2016 Status changed from recruiting to completed.
- 02 Dec 2013 Planned end date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 29 Nov 2012 New trial record